Macrophage activation syndrome is a rare and potentially life threatening complication of childhood rheumatic disorders. It is described most commonly with systemic onset juvenile idiopathic arthritis (soJIA). The major clinical manifestations are non-remitting fever, hepatosplenomegaly, lymphadenopathy, bleeding diathesis, altered mental status and rash and may mimic a fl are of soJIA. The characteristic laboratory fi ndings are leucopenia, thrombocytopenia and dramatic elevation of urinary β2 microglobulin. Corticosteroids and cyclosporine are the drugs commonly used in its management. Early diagnosis and prompt treatment can be life saving. We report a case of 12 year old female child with inadequately treated systemic onset juvenile idiopathic arthritis who developed fatal macrophage activation syndrome. The diagnosis and management of macrophage activation syndrome are discussed.
M acrophage activation syndrome (MAS) is a clinical syndrome caused by excessive activation and proliferation of well-differentiated macrophages. MAS occur in heterogeneous group of conditions including infections, neoplasms, drug induced and rheumatic disorders. It is described most commonly with systemic onset juvenile idiopathic arthritis (soJIA) 1, 2 . Most of the previously reported patients with soJIA and MAS were under regular therapy for the arthritis. We herein describe a patient with inadequately treated soJIA who developed macrophage activation syndrome, thereby causing a diagnostic confusion between fl are of soJIA and MAS.
Case report
A 12 yrs old female presented with a 10-day history of high grade continuous fever and cough along with progressive abdominal distension for 8 days, breathlessness for 2 days, and swelling over the feet for 1 day. She was symptomatic from last 4 years with swelling, pain and formation of deformity in multiple joints, and had been diagnosed as systemic onset juvenile idiopathic arthritis (soJIA) 1 year back and was being treated with naproxen. Patient had only partial relief of symptoms and was not taking the drug regularly or coming for regular review. The parents had stopped naproxen, 2 months back and were using some traditional (ayurvedic) drugs.
On examination at admission, patient was cooperative but resented handling. She had respiratory distress with respiratory rates of 39/min, intercostals retractions, severe pallor, bilateral small cervical lymph nodes and pedal edema. Bilateral ankle joints were swollen and tender. Joint deformities were present in bilateral knee, elbow, wrist and proximal and distal interphalangeal joints. Chest examination revealed right sided crepitations. Liver was 6 cm below costal margin in mid-clavicular line and spleen was 5 cm below costal margin. Haemoglobin was 5.4 gm/100ml, total leucocytes count was 8300 x 10 9 /L (polymorphs 61%, lymphocytes 35%, eosinophils 2% and monocytes 2%) and platelet count of 58,000 x 10 9 /L. Blood urea was 85 mg/100ml and serum creatinine was 4.1 mg/ 100ml. Further investigations were requisitioned and a provisional diagnosis of fl are of soJIA with pneumonia was entertained, and treatment started with intravenous fl uids, injection Ceftriaxone and blood transfusion.
ESR was markedly raised (135 mm in 1 st hour). Liver enzymes (Alanine aminotransferase 72 U/L, Aspartate aminotransferase 106 U/L, Alkaline phosphatase 1756 U/L) were raised. C-reactive protein and rheumatoid factor were positive. Serum ferritin was 1338 ng/ ml. Chest radiograph showed right paracardiac pneumonia. Ultrasonography of the abdomen showed hepatosplenomegaly and renomegaly with increased renal cortical echogenecity with accentuated corticomedullary differentiation.
Over the next 24 hours, patient continued to be ill with fever and respiratory distress persisting and worsening of the mental status with severe irritability. In view of presence of hepatosplenomegaly, pancytopenia and worsening of mental status possibility of macrophage activation syndrome (MAS) was considered and bone marrow aspiration was performed. Cultures obtained were sterile and steroids were started. Patient had further worsening of sensorium and died on the same day. Bone marrow aspiration revealed macrophages phagocytosing hematopoeitic elements. The fi nal diagnosis was soJIA with MAS with pneumonia with possible renal amyloidosis.
Discussion
MAS has been described in association with soJIA with various triggering events like bacterial and viral illness (Ebstein-Barr Virus and hepatitis A infection are most commonly associated) and drugs like non-steroidal anti-infl ammatory drugs, gold salts, sulfasalazine, methotrexate and even etanercept 1,3-8 .
MAS bear close resemblance to a histiocytic disorder, secondary hemophagocytic lymphohistiocytosis. Precise underlying mechanisms have not been defi ned. Studies have described overproduction of cytokines originating from activated T lymphocytes and macrophage, dysfunction of natural killer cells and reduced expression of perforin (the protein that controls the cytotoxic activity of natural killer cells and T lymphocytes) in patients with MAS 9, 10 . Clinically macrophage activation syndrome has a dramatic onset and may mimic a fl are of soJIA. It can occur as a initial manifestation of soJIA 1, 2 . The major clinical manifestations of MAS are non-remitting fever, hepatosplenomegaly, lymphadenopathy, bleeding diathesis, altered mental status and rash 1, 2 . Large pericardial effusion is also described in one case report 11 . The common causes of death in these patients are acute respiratory distress syndrome and central nervous system involvement 2 . A fl are of soJIA can present with arthritis, quotidian fever, hepatosplenomegaly, lymphadenopathy, evanescent rash and serositis. The common laboratory fi ndings are leucocytosis, thrombocytosis, elevated ESR and hyperfi brinogenemia. We missed the diagnosis of MAS initially because arthritis was present, there were no mental changes, ESR was elevated and patient was inadequately treated, mimicking the fl are of disease.
The characteristic laboratory fi ndings in patient with MAS are leucopenia, thrombocytopenia and dramatic elevation of urinary β2 microglobulin; with deranged coagulation profi le with hypofi brinogenemia, deranged liver function tests, low ESR and anemia being commonly present 1, 2 . Hyperferritenemia and elevation of serum lactate dehydrogenase are also present in many cases 2 . Derangement of renal function tests can occur during course of disease and has been implicated as a poor prognostic marker in one study 1 . Other less common fi ndings include hypertriglyceridemia, hypoalbuminemia and hyponatremia 2 . Studies have documented elevation of serum β2 microglobulin, soluble interlukin-2 receptor and soluble CD163 in patients with MAS and are promising diagnostic markers 2, 12 . The pathologic fi nding on bone marrow aspiration is the presence of well-differentiated macrophages actively phagocytosing hematopoeitic elements.
MAS has aggressive clinical course and, early recognition and treatment is imperative. Death rates of 11-22 % are reported 1, 2 . Corticosteroids and cyclosporine are most commonly used drugs. Cyclosporine has been reported to produce prompt response when used in severe cases and in those who fail to respond to steroids 2, 13 . Cyclosporine may be chosen as a fi rst line therapy or added to fi rst line steroid treatment 2 . Other treatment options include plasma exchanges, intravenous immunoglobulins and etoposide 11 . Recently, Etanercept has been found to be useful in therapy resistant cases 14, 15 .
Conclusions
Macrophage activation syndrome can occur in heterogeneous group on conditions but it is most commonly described with soJIA. MAS may be a presenting manifestation of soJIA or can occur during the course of disease and may mimic a fl are of soJIA. The clinical fi ndings of non-remitting fever, hepatosplenomegaly and altered mentation along with laboratory fi ndings of leucopenia and thrombocytopenia should alert the physician of this condition. Early recognition and prompt treatment of this life threatening condition with corticosteroids or cyclosporine is vital.
